drugset / Trial / NCT05167370
High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a study of amifostine to determine how effective it is in the reduction of infection in a high dose chemotherapy regimen with autologous stem cell rescue in children with high risk, relapsed or refractory pediatric solid tumors.
Timeline
- Start
- 2010-12-13
- Primary completion
- 2011-04-29
- Completion
- 2012-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | amifostine | Unknown | 1125 mg/m2 | Intravenous |